Market Cap 137.07B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 7.87
Forward PE 8.07
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 13,137,803
Avg Vol 42,230,012
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 66%
Beta 0.35
Analysts Sell
Price Target $28.98

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
HiddenCycles
HiddenCycles Jul. 10 at 5:10 PM
Banked from @TopSarge alerts the last few weeks, timing’s been on point! Follow him so you don't miss out 🔥 $ARQQ $UUUU $PFE $LAES soon
0 · Reply
jack1342
jack1342 Jul. 10 at 4:47 PM
$PFE soon, this will breakout of this range.
1 · Reply
LUNR_SpacEx_onSteroids
LUNR_SpacEx_onSteroids Jul. 10 at 4:36 PM
$CMPS $LLY $PFE What a no brainer here A DEFINITE BUY - GO AWAY - RETIRE type stock. At least a DOUBLE DOUBLE 💰💰 X 💰💰🤑
1 · Reply
BarkingPuppy
BarkingPuppy Jul. 10 at 4:17 PM
$ELTP $PFE $JNJ $MRNA $GME This is why ELTP is going to be the biggest stock of 2027. Its all about SequestOx... Here is the info. Look it up. Why SequestOx is Great Addresses the Opioid Crisis: With opioid addiction being a major public health issue, SequestOx offers a safer alternative for patients who need strong pain relief but are at risk of misuse or abuse. Effective Pain Relief: The oxycodone component ensures that patients receive immediate and effective relief from moderate to severe pain, improving quality of life. Innovative Abuse-Deterrent Design: The sequestered naltrexone technology is a significant advancement in pharmaceutical formulations, combining efficacy with safety. Regulatory Progress: SequestOx has been under development with regulatory filings and pivotal bioequivalence studies underway, highlighting ELTP’s commitment to bringing this important medication to market.
0 · Reply
Mithlorien
Mithlorien Jul. 10 at 4:16 PM
$PFE watching this stock makes me want to nap everytime🤣
1 · Reply
Micheal_Pothead
Micheal_Pothead Jul. 10 at 3:53 PM
$PFE throwback to when I almost sold out at break even on April fools day to switch to SOFI… Would have 50,000 more dollars right now if I did
0 · Reply
Micheal_Pothead
Micheal_Pothead Jul. 10 at 3:41 PM
$PFE 24.24 forever I guess
1 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jul. 10 at 3:40 PM
$PFE - At least we aren’t as red as our pharma-ey neighbours!
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jul. 10 at 3:16 PM
$PFE All news is bad for us because the only time were allowed to go up is when wall st forgets that we exist. Any good headline just reminds everyone that there is a Pfizer they can go sell
1 · Reply
Micheal_Pothead
Micheal_Pothead Jul. 10 at 3:06 PM
$PFE flat on double good news is actually good for us 🫩
0 · Reply
Latest News on PFE
Pfizer price target lowered to $26 from $27 at BofA

2026-07-10T10:30:21.000Z - 7 hours ago

Pfizer price target lowered to $26 from $27 at BofA


Pfizer price target lowered to $28 from $30 at JPMorgan

2026-07-08T12:15:37.000Z - 2 days ago

Pfizer price target lowered to $28 from $30 at JPMorgan


Pfizer (PFE) Stock Bounces Back After an Analyst Downgrade

2026-07-07T15:54:25.000Z - 3 days ago

Pfizer (PFE) Stock Bounces Back After an Analyst Downgrade


Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 4 days ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low


Pfizer downgraded to Hold from Buy at HSBC

2026-07-06T09:50:29.000Z - 4 days ago

Pfizer downgraded to Hold from Buy at HSBC


Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 15 days ago

Pfizer Declares Third-Quarter 2026 Dividend


Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 16 days ago

Pfizer dismissed from US states' drug price-fixing lawsuit


Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 22 days ago

Pfizer CFO Dave Denton to step down, leave company in August


Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 22 days ago

Pfizer Announces Chief Financial Officer Transition


US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 4 weeks ago

US FDA approves Pfizer's bleeding disorder drug for children


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 4 weeks ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 4 weeks ago

Pfizer Slides: Study update


Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 4 weeks ago

Pfizer Press release: Study update


Mailbag: A Follow-Up on Pfizer & Other Questions

May 30, 2026, 9:22 AM EDT - 5 weeks ago

Mailbag: A Follow-Up on Pfizer & Other Questions

AGNC LAND NLY PFFA


Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 2 months ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC


Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 2 months ago

Pfizer CEO on AI-designed molecule, and race to use new tech


3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 2 months ago

3 Dividend Stocks for May 2026

SYY WSO


Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Earnings Call Transcript: Q1 2026


Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Earnings release: Q1 2026


Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Quarterly report: Q1 2026


Pfizer Slides: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Slides: Q1 2026


Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 2 months ago

Pfizer Posts Better-Than-Expected Revenue, Profit


Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:23 AM EDT - 2 months ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending


Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 2 months ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS


HiddenCycles
HiddenCycles Jul. 10 at 5:10 PM
Banked from @TopSarge alerts the last few weeks, timing’s been on point! Follow him so you don't miss out 🔥 $ARQQ $UUUU $PFE $LAES soon
0 · Reply
jack1342
jack1342 Jul. 10 at 4:47 PM
$PFE soon, this will breakout of this range.
1 · Reply
LUNR_SpacEx_onSteroids
LUNR_SpacEx_onSteroids Jul. 10 at 4:36 PM
$CMPS $LLY $PFE What a no brainer here A DEFINITE BUY - GO AWAY - RETIRE type stock. At least a DOUBLE DOUBLE 💰💰 X 💰💰🤑
1 · Reply
BarkingPuppy
BarkingPuppy Jul. 10 at 4:17 PM
$ELTP $PFE $JNJ $MRNA $GME This is why ELTP is going to be the biggest stock of 2027. Its all about SequestOx... Here is the info. Look it up. Why SequestOx is Great Addresses the Opioid Crisis: With opioid addiction being a major public health issue, SequestOx offers a safer alternative for patients who need strong pain relief but are at risk of misuse or abuse. Effective Pain Relief: The oxycodone component ensures that patients receive immediate and effective relief from moderate to severe pain, improving quality of life. Innovative Abuse-Deterrent Design: The sequestered naltrexone technology is a significant advancement in pharmaceutical formulations, combining efficacy with safety. Regulatory Progress: SequestOx has been under development with regulatory filings and pivotal bioequivalence studies underway, highlighting ELTP’s commitment to bringing this important medication to market.
0 · Reply
Mithlorien
Mithlorien Jul. 10 at 4:16 PM
$PFE watching this stock makes me want to nap everytime🤣
1 · Reply
Micheal_Pothead
Micheal_Pothead Jul. 10 at 3:53 PM
$PFE throwback to when I almost sold out at break even on April fools day to switch to SOFI… Would have 50,000 more dollars right now if I did
0 · Reply
Micheal_Pothead
Micheal_Pothead Jul. 10 at 3:41 PM
$PFE 24.24 forever I guess
1 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jul. 10 at 3:40 PM
$PFE - At least we aren’t as red as our pharma-ey neighbours!
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jul. 10 at 3:16 PM
$PFE All news is bad for us because the only time were allowed to go up is when wall st forgets that we exist. Any good headline just reminds everyone that there is a Pfizer they can go sell
1 · Reply
Micheal_Pothead
Micheal_Pothead Jul. 10 at 3:06 PM
$PFE flat on double good news is actually good for us 🫩
0 · Reply
Micheal_Pothead
Micheal_Pothead Jul. 10 at 3:03 PM
$PFE miserable
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jul. 10 at 3:02 PM
0 · Reply
Micheal_Pothead
Micheal_Pothead Jul. 10 at 3:00 PM
$PFE lol…. Yeah..
0 · Reply
_Crim_Jamer_
_Crim_Jamer_ Jul. 10 at 2:59 PM
$PFE knew it couldn't stay green.
0 · Reply
Typecheck
Typecheck Jul. 10 at 2:58 PM
$PFE https://seekingalpha.com/news/4612955-pfizer-wins-fda-label-expansion-padcev-plus-mercks-keytruda Let's go negative on double good news day. Unbelievable.
0 · Reply
Hairoglyphics
Hairoglyphics Jul. 10 at 2:56 PM
https://www.cnbc.com/amp/2026/06/30/anthropic-launches-ai-drug-discovery-program-claude-science.html $PFE $ABBV $SDGR $MU $TELIF
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jul. 10 at 2:37 PM
$PFE Cant you do anything ever!!!!????????
0 · Reply
TraderDaKing
TraderDaKing Jul. 10 at 2:08 PM
$ELTP $GME $WEN $PFE $DJT News Coming, Trump is on our side to help. Pharmaceuticals (ticker symbol ELTP) is a specialty pharmaceutical company based in Northvale, New Jersey, founded in 1997. It focuses on the development, manufacturing, and distribution of oral, controlled-release niche generic drug products. Recently, ELTP has been active in filing abbreviated new drug applications with the U.S. Food and Drug Administration, indicating ongoing efforts to expand its portfolio in the generic drug market. While ELTP is recognized as a growing player in the U.S. pharmaceutical sector, especially in niche generics, it widely described as "the next great drug company" on the scale of major innovators or blockbuster drug developers. However, its strategic focus on controlled-release generics and recent regulatory filings suggest it is positioning itself for growth and increased market presence.
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jul. 10 at 1:54 PM
$PFE We dont lead the pack very often, but when we do its not very impressive
2 · Reply
nimii
nimii Jul. 10 at 1:37 PM
$PFE 😤
0 · Reply
Typecheck
Typecheck Jul. 10 at 1:33 PM
$PFE can't go up a lousy cent when major competitor drug trial fails
1 · Reply
BarkingPuppy
BarkingPuppy Jul. 10 at 1:15 PM
0 · Reply